Skip to main content

Featured

Weekly Market Snapshot: TSX Hits Record High, Then Retreats as Fed Shocks Markets

  Week of June 16–20, 2026  |  Published June 20, 2026 It was a week of records and reversals for Canadian investors. The TSX touched an all-time high midweek before a hawkish surprise from the U.S. Federal Reserve and falling oil prices — triggered by the U.S.–Iran interim peace deal — pulled markets lower into Thursday's close. Here's everything that moved the needle for your portfolio and wallet this week. 📊 Weekly Market Scorecard Index / Asset Level (June 19 Close) Week Change S&P/TSX Composite 34,857 ▼ Mixed (high: 35,629 Wed.) S&P 500 (USD) 7,500.58 ▲ +1.08% (Wed.) Dow Jones (USD) 51,564.70 ▲ +0.14% (Wed.) Nasdaq (USD) 26,517.93 ▲ +1.91% (Wed.) WTI Crude Oil (USD/barrel) ~$76.54 ▼ Sharp weekly decline Gold (USD/oz) ~$4,157 ▼ Fell on hawkish Fed CAD/USD (Loonie) ~$0.7068 ▼ Under pressure Note: U.S. markets were closed Friday, June 20, for the Juneteenth National Independence Day holiday. TSX figures reflect Thursday's close. 🇨🇦 TSX: A Record High That Did...

article

Provincial Directive Curbs AHS Authority Over Private Surgical Contract Negotiations

 


In a significant policy shift, Alberta Health Minister Adriana LaGrange has stripped Alberta Health Services (AHS) of its authority to negotiate contracts with private surgical facilities. According to a government directive obtained by media, the change came after internal concerns—raised by the agency’s then-chief executive—over rising contract costs.

Documents, including a letter from former AHS CEO Athana Mentzelopoulos’s lawyer, allege that senior government officials—even involving Premier Danielle Smith’s former chief of staff—intervened in AHS’s procurement process to favor private companies. This interference reportedly undermined AHS’s established negotiation powers and raised serious questions about transparency in the province’s health system. 

A separate report in a Morning Update from Unpublished Newswire reiterated the move, noting that the directive is part of broader reforms aimed at reducing costs by leveraging competitive pricing in surgical services.  Meanwhile, a CityNews investigation has added context to the controversy, citing denials by private surgical providers who label the allegations of sweetheart deals as “false and baseless.” 

Critics and opposition leaders are calling for further inquiry into the decision-making process behind these changes, arguing that the shift could signal a move toward greater privatization of public health services. In contrast, government representatives insist that the directive is intended solely to improve efficiency and ensure more competitive pricing for publicly funded operations.

Comments